Eligible cohorts for spring 2024 COVID-19 vaccination

The following clinical at-risk groups within scope of this digital cohort development will receive invitations to present for a COVID-19 spring 2024 vaccination (as specified by NHS England) are:

Adults aged 16 years and over diagnosed with:

• immunosuppression

Children 6 months to and 15 years inclusive diagnosed with:

• immunosuppression

Age based cohorting:

• people aged 75 years or over before 30 June 2024

The clinical at-risk groups within scope of this digital cohort development (as specified by NHS England) are:

Adults aged 16 years and over diagnosed with:

• chronic respiratory disease
• chronic heart disease and vascular disease
• chronic kidney disease
• chronic liver disease
• chronic neurological disease
• diabetes mellitus and other endocrine disorders
• immunosuppression
• asplenia or dysfunction of the spleen
• morbidly obese
• severe mental illness

Children 6 months to 15 years inclusive diagnosed with:

• chronic respiratory disease
• chronic heart conditions
• chronic conditions of the kidney, liver, or digestive system
• chronic neurological disease
• endocrine disorders
• immunosuppression
• asplenia or dysfunction of the spleen
• serious genetic abnormalities that affect a number of systems

Age based cohorting:

• People aged 75 years or over before 30 June 2024

This web page outlines NHS England’s Cohorting as a Service's (CaaS) approach to deliver this cohort using established methodologies. It also highlights any divergence from the clinical criteria held within tables 3 and 4 of Chapter 14a of the Green Book and associated assumptions.